Works matching DE "CANDESARTAN"

Results: 313

Headache medication and the COVID-19 pandemic.

Published in:

2020

By:

MaassenVanDenBrink, Antoinette;
de Vries, Tessa;
Danser, A. H. Jan

Publication type:

Letter

Efficacy and safety of lasmiditan in patients using concomitant migraine preventive medications: findings from SAMURAI and SPARTAN, two randomized phase 3 trials.

Published in:

Journal of Headache & Pain, 2019, v. 20, n. 1, p. N.PAG, doi. 10.1186/s10194-019-1032-x

By:

Loo, Li Shen;
Ailani, Jessica;
Schim, Jack;
Baygani, Simin;
Hundemer, Hans-Peter;
Port, Martha;
Krege, John H.

Publication type:

Article

Consensus of the Hellenic Headache Society on the diagnosis and treatment of migraine.

Published in:

Journal of Headache & Pain, 2019, v. 20, n. 1, p. 1, doi. 10.1186/s10194-019-1060-6

By:

Kouremenos, Evangelos;
Arvaniti, Chrysa;
Constantinidis, Theodoros S.;
Giannouli, Ermioni;
Fakas, Nikolaos;
Kalamatas, Themistoklis;
Kararizou, Evangelia;
Naoumis, Dimitrios;
Mitsikostas, Dimos D.

Publication type:

Article

Drug administration via feeding tubes—a procedure that carries risks: systematic identification of critical factors based on commonly administered drugs in a cohort of stroke patients.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 11, p. 1599, doi. 10.1007/s00228-024-03723-4

By:

Sommerfeldt, Jana;
Sartorius, Hannes;
von Sarnowski, Bettina;
Klein, Sandra;
Ritter, Christoph A.

Publication type:

Article

A collaborative study of the impact of N-nitrosamines presence and ARB recall on ARB utilization – results from IQVIA™ Disease Analyzer Germany.

Published in:

European Journal of Clinical Pharmacology, 2023, v. 79, n. 6, p. 849, doi. 10.1007/s00228-022-03439-3

By:

Hedenmalm, Karin;
Quinten, Chantal;
Kurz, Xavier;
Bradley, Marie;
Lee, Hana;
Eworuke, Efe

Publication type:

Article

Long-term protection and mechanism of pacing-induced postconditioning in the heart.

Published in:

Basic Research in Cardiology, 2010, v. 105, n. 4, p. 523, doi. 10.1007/s00395-010-0095-2

By:

Babiker, Fawzi A.;
Lorenzen-Schmidt, Ilka;
Mokelke, Eric;
Vanagt, Ward Y.;
Delhaas, Tammo;
Waltenberger, Johannes;
Cleutjens, Jack P.;
Prinzen, Frits W.

Publication type:

Article

A Robust and Reliable UPLC Method for the Simultaneous Quantification of Rosuvastatin Calcium, Glibenclamide, and Candesartan Cilexetil.

Published in:

Separations (2297-8739), 2024, v. 11, n. 4, p. 113, doi. 10.3390/separations11040113

By:

Ibrahim, Mohamed Abbas;
Sherif, Abdelrahman Y.;
Alshora, Doaa;
Alsaadi, Badr

Publication type:

Article

Formulation and validation of Candesartan cilexetil-loaded nanosuspension to enhance solubility.

Published in:

Pharmacia (0428-0296), 2024, v. 71, n. 1, p. 1, doi. 10.3897/pharmacia.71.e114943

By:

Al-Edresi, Sarmad;
Hamrah, Karrar Albo;
Al-Shaibani, Abulfadhel

Publication type:

Article

Analytical quality by design-based RP-HPLC method for quantification of pioglitazone and candesartan cilexetil in bilayer tablet and its forced degradation studies.

Published in:

Pharmacia (0428-0296), 2023, v. 70, n. 1, p. 27, doi. 10.3897/pharmacia.70.e95099

By:

Kola, Hephzibah;
Shanmugasundaram, Sangeetha

Publication type:

Article

ANALYSIS OF FUNCTIONAL CHANGES UNDER USING OF CANDESARTAN CILEXETIL WITH RESVERATROL IN ANIMA.

Published in:

Bulletin of Taras Shevchenko National University of Kyiv / Vestnik Kievskogo Nacional'Nogo Universiteta Imeni Tarasa Ševčenko, 2021, v. 84, n. 1, p. 24, doi. 10.17721/1728_2748.2021.84.24–27

By:

Beliayeva, A.;
Garmanchuk, L.

Publication type:

Article

CHANGING IN THE NUMBER OF CD117+ STEM CELLS, CYTOGENETIC AND CYTOKINETIC PARAMETERS UNDER THE USING OF CANDESARTAN, CANDESARTAN CILEXETIL AND RESVERATROL IN VITRO.

Published in:

Bulletin of Taras Shevchenko National University of Kyiv / Vestnik Kievskogo Nacional'Nogo Universiteta Imeni Tarasa Ševčenko, 2019, v. 79, n. 3, p. 54, doi. 10.17721/1728_2748.2019.79.54-57

By:

Beliayeva, А.;
Garmanchuk, L.

Publication type:

Article

A Systematic Review of Add-on Pharmacologic Therapy in the Treatment of Resistant Hypertension.

Published in:

American Journal of Cardiovascular Drugs, 2017, v. 17, n. 4, p. 311, doi. 10.1007/s40256-017-0224-5

By:

Tataru, Anita;
Barry, Arden

Publication type:

Article

Candesartan Cilexetil.

Published in:

American Journal of Cardiovascular Drugs, 2010, v. 10, n. 5, p. 335, doi. 10.2165/11206300-000000000-00000

By:

Hoy, Sheridan M.;
Keating, Gillian M.

Publication type:

Article

Is Ace Inhibitor/Angiotensin-Receptor Blocker Associated with Acute Kidney Injury Post-Coronary Artery Bypass Grafting in a Mixed Ethnicity Population in a Community-Based Hospital in Hawai'i?

Published in:

Hawaii Journal of Medicine & Public Health, 2013, v. 72, n. 9, p. 44

By:

Toledo, Ma Clarisse;
Tantisattamo, Ekamol;
Shigaki, Dorothy;
Ng, Roland C. K.

Publication type:

Article

Urinary peptidome and diabetic retinopathy in the DIRECT‐Protect 1 and 2 trials.

Published in:

Diabetic Medicine, 2021, v. 38, n. 9, p. 1, doi. 10.1111/dme.14634

By:

Rotbain Curovic, Viktor;
Magalhães, Pedro;
He, Tianlin;
Hansen, Tine W.;
Mischak, Harald;
Rossing, Peter

Publication type:

Article

Chemometric Methods for Simultaneous Determination of Candesartan Cilexetil and Hydrochlorothiazide in Binary Combinations.

Published in:

Journal of Analytical Methods in Chemistry, 2023, p. 1, doi. 10.1155/2023/5107317

By:

Ali, Diyar Salahuddin

Publication type:

Article

COMPARATIVE STUDY ON THE EFFICIENCY OF THE ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN II RECEPTOR ANTAGONISTS IN REDUCING SERUM C-REACTIVE PROTEIN LEVELS IN PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION.

Published in:

Therapeutics, Pharmacology & Clinical Toxicology, 2010, v. 14, n. 2, p. 108

By:

Cioca, Gabriela;
Boitan, Minerva;
Zaharie, Alina;
Safta, L.

Publication type:

Article

Enhanced Antihypertensive Activity of Candesartan Cilexetil Nanosuspension: Formulation, Characterization and Pharmacodynamic Study.

Published in:

Scientia Pharmaceutica, 2011, v. 79, n. 3, p. 635, doi. 10.3797/scipharm.1103-17

By:

DETROJA, Chetan;
CHAVHAN, Sandip;
SAWANT, Krutika

Publication type:

Article

Cramming on potato starch as a novel superdisintegrant for depiction and characterization of candesartan cilexetil fast dissolving tablet.

Published in:

Thai Journal of Pharmaceutical Sciences, 2021, v. 45, n. 2, p. 137

By:

Vemuri, Venkata Deepthi;
Nalla, Swathi;
Gowri, Gollu;
Mathala, Nalini

Publication type:

Article

Candesartan Improves Ischemia-Induced Impairment of the Blood-Brain Barrier In Vitro.

Published in:

Cellular & Molecular Neurobiology, 2015, v. 35, n. 4, p. 563, doi. 10.1007/s10571-014-0152-8

By:

So, Gohei;
Nakagawa, Shinsuke;
Morofuji, Yoichi;
Hiu, Takeshi;
Hayashi, Kentaro;
Tanaka, Kunihiko;
Suyama, Kazuhiko;
Deli, Maria;
Nagata, Izumi;
Matsuo, Takayuki;
Niwa, Masami

Publication type:

Article

Candesartan not beneficial in patients with acute stroke and raised BP.

Published in:: Australian Journal of Pharmacy, 2011, v. 92, n. 1095, p. 83
Publication type:: Article

Losartan has a higher death risk than candesartan.

Published in:: Australian Journal of Pharmacy, 2011, v. 92, n. 1095, p. 84
Publication type:: Article

High doses of candesartan can reduce proteinuria in kidney failure.

Published in:: Australian Journal of Pharmacy, 2009, v. 90, n. 1070, p. 76
Publication type:: Article

Appropriate nomenclature: angiotensin II receptors.

Published in:

2015

By:

D'Amore, A;
Mitchell, EKL

Publication type:

Letter to the Editor

Candesartan restores pressure-induced vasodilation and prevents skin pressure ulcer formation in diabetic mice.

Published in:

Cardiovascular Diabetology, 2015, v. 14, n. 1, p. 1, doi. 10.1186/s12933-015-0185-4

By:

Danigo, Aurore;
Nasser, Mohamad;
Bessaguet, Flavien;
Javellaud, James;
Oudart, Nicole;
Achard, Jean-Michel;
Demiot, Claire

Publication type:

Article

Effects of co-administration of candesartan with pioglitazone on inflammatory parameters in hypertensive patients with type 2 diabetes mellitus: a preliminary report.

Published in:

Cardiovascular Diabetology, 2013, v. 12, n. 1, p. 1, doi. 10.1186/1475-2840-12-71

By:

Suzuki, Hirofumi;
Sakamoto, Masaya;
Hayashi, Takeshi;
Iuchi, Hiroyuki;
Ohashi, Kennosuke;
Isaka, Tsuyoshi;
Sakamoto, Noriko;
Kayama, Yosuke;
Tojo, Katsuyoshi;
Yoshimura, Michihiro;
Utsunomiya, Kazunori

Publication type:

Article

Effects of candesartan in hypertensive patients with type 2 diabetes mellitus on inflammatory parameters and their relationship to pulse pressure.

Published in:

Cardiovascular Diabetology, 2012, v. 11, n. 1, p. 118, doi. 10.1186/1475-2840-11-118

By:

Sakamoto, Masaya;
Suzuki, Hirofumi;
Hayashi, Takeshi;
Iuchi, Hiroyuki;
Isaka, Tsuyoshi;
Sakamoto, Noriko;
Kayama, Yosuke;
Tojo, Katsuyoshi;
Yoshimura, Michihiro;
Utsunomiya, Kazunori

Publication type:

Article

Comparative effect of olmesartan and candesartan on lipid metabolism and renal function in patients with hypertension: a retrospective observational study.

Published in:: Cardiovascular Diabetology, 2011, v. 10, n. 1, p. 74, doi. 10.1186/1475-2840-10-74
Publication type:: Article

Reflex systemic sympatho-neural response to brachial adenosine infusion in treated heart failure.

Published in:

European Journal of Heart Failure, 2011, v. 13, n. 5, p. 475, doi. 10.1093/eurjhf/hfr005

By:

Wijeysundera, Harindra C.;
Parmar, Gurpreet;
Rongen, Gerard A.;
Floras, John S.

Publication type:

Article

Is the effect of angiotensin receptor blockade in patients with heart failure modified by treatment with aspirin? The answer is not so clear!

Published in:

2010

By:

Massie, Barry M.

Publication type:

Editorial

Efficacy and safety of angiotensin receptor blockade are not modified by aspirin in patients with chronic heart failure: a cohort study from the Candesartan in Heart failure – Assessment of Reduction in Mortality and morbidity (CHARM) programme.

Published in:

European Journal of Heart Failure, 2010, v. 12, n. 7, p. 738, doi. 10.1093/eurjhf/hfq065

By:

Su Min Chang;
Granger, Christopher B.;
Johansson, Peter A.;
Kosolcharoen, Peter;
McMurray, John J. V.;
Michelson, Eric L.;
Murray, David R.;
Olofsson, Bertil;
Pfeffer, Marc A.;
Solomon, Scott D.;
Swedberg, Karl;
Yusuf, Salim;
Dunlap, Mark E.

Publication type:

Article

Baseline characteristics and outcomes of patients with heart failure receiving bronchodilators in the CHARM programme.

Published in:

European Journal of Heart Failure, 2010, v. 12, n. 6, p. 557, doi. 10.1093/eurjhf/hfq040

By:

Hawkins, Nathaniel M.;
Wang, Duolao;
Petrie, Mark C.;
Pfeffer, Marc A.;
Swedberg, Karl;
Granger, Christopher B.;
Yusuf, Salim;
Solomon, Scott D.;
Östergren, Jan;
Michelson, Eric L.;
Pocock, Stuart J.;
Maggioni, Aldo P.;
McMurray, John J. V.

Publication type:

Article

Perceived benefit after participating in positive or negative/neutral heart failure trials: the patients' perspective.

Published in:

2001

By:

Yuval, Rita;
Uziel, Klari;
Gordon, Nomi;
Merdler, Amnon;
Khader, Nader;
Karkabi, Basheer;
Flugelman, Moshe Y.;
Halon, David A.;
Lewis, Basil S.;
Yuval, R;
Uziel, K;
Gordon, N;
Merdler, A;
Khader, N;
Karkabi, B;
Flugelman, M Y;
Halon, D A;
Lewis, B S

Publication type:

journal article

Acute renal failure when exenatide is co-administered with diuretics and angiotensin II blockers.

Published in:

Pharmacy World & Science, 2010, v. 32, n. 5, p. 559, doi. 10.1007/s11096-010-9423-8

By:

López-Ruiz, Alfonso;
Peso-Gilsanz, Cristina;
Meoro-Avilés, Amparo;
Soriano-Palao, José;
Andreu, Alberto;
Cabezuelo, Juan;
Arias, José

Publication type:

Article

Attenuation of increased secretory leukocyte protease inhibitor, matricellular proteins and angiotensin II and left ventricular remodeling by candesartan and omapatrilat during healing after reperfused myocardial infarction.

Published in:

Molecular & Cellular Biochemistry, 2013, v. 376, n. 1/2, p. 175, doi. 10.1007/s11010-013-1565-2

By:

Palaniyappan, Ariv;
Uwiera, Richard;
Idikio, Halliday;
Menon, Vijay;
Jugdutt, Catherine;
Jugdutt, Bodh

Publication type:

Article

Comparison of vasopeptidase inhibitor omapatrilat and angiotensin receptor blocker candesartan on extracellular matrix, myeloperoxidase, cytokines, and ventricular remodeling during healing after reperfused myocardial infarction.

Published in:

Molecular & Cellular Biochemistry, 2009, v. 321, n. 1/2, p. 9

By:

Arivazhagan Palaniyappan;
Richard Uwiera;
Halliday Idikio

Publication type:

Article

Development of a novel [<sup>18</sup>F]fluorobenzyl derivative of the AT<sub>1</sub> receptor antagonist Candesartan.

Published in:

Journal of Labelled Compounds & Radiopharmaceuticals, 2021, v. 64, n. 3, p. 120, doi. 10.1002/jlcr.3892

By:

Alonso Martinez, Luis Michel;
DaSilva, Jean N.

Publication type:

Article

Radioiodination and biological evaluation of candesartan as a tracer for cardiovascular disorder detection.

Published in:

Journal of Labelled Compounds & Radiopharmaceuticals, 2016, v. 59, n. 12, p. 484, doi. 10.1002/jlcr.3435

By:

Sanad, M.H.;
Sallam, Kh.M.;
Marzook, F.A.;
Abd ‐ Elhaliem, S.M.

Publication type:

Article

Angiotensin II receptor antagonists against migraine in pregnancy: fatal outcome.

Published in:

Journal of Headache & Pain, 2010, v. 11, n. 2, p. 167, doi. 10.1007/s10194-009-0182-7

By:

Haaland, Kirsti

Publication type:

Article

The inhibition of renin-angiotensin system in advanced pancreatic cancer: an exploratory analysis in 349 patients.

Published in:

Journal of Cancer Research & Clinical Oncology, 2015, v. 141, n. 5, p. 933, doi. 10.1007/s00432-014-1873-2

By:

Nakai, Yousuke;
Isayama, Hiroyuki;
Sasaki, Takashi;
Takahara, Naminatsu;
Saito, Kei;
Ishigaki, Kazunaga;
Hamada, Tsuyoshi;
Mizuno, Suguru;
Miyabayashi, Koji;
Yamamoto, Keisuke;
Mohri, Dai;
Kogure, Hirofumi;
Yamamoto, Natsuyo;
Ijichi, Hideaki;
Tateishi, Keisuke;
Tada, Minoru;
Koike, Kazuhiko

Publication type:

Article

Effects of Candesartan vs Lisinopril on Neurocognitive Function in Older Adults With Executive Mild Cognitive Impairment: A Randomized Clinical Trial.

Published in:

JAMA Network Open, 2020, v. 3, n. 8, p. e2012252, doi. 10.1001/jamanetworkopen.2020.12252

By:

Hajjar, Ihab;
Okafor, Maureen;
McDaniel, Darius;
Obideen, Malik;
Dee, Elizabeth;
Shokouhi, Mahsa;
Quyyumi, Arshed A.;
Levey, Allan;
Goldstein, Felicia

Publication type:

Article

Formulation of Candesartan Cilexetil Nanoparticles by Ionotropic Gelation Method Using Ultrasonication.

Published in:

Indian Journal of Pharmaceutical Education & Research, 2023, v. 57, n. 3, p. 728, doi. 10.5530/ijper.57.3.88

By:

Bisht, Tanuja;
Bolmal, U. B.;
Nainwal, Nidhi

Publication type:

Article

Liquisolid Compact Tablet of Candesartan Cilexetil with Enhanced Solubility using Neusilin US2, Aerosil 200 and Transcutol HP.

Published in:

Indian Journal of Pharmaceutical Education & Research, 2019, v. 53, n. 3, p. 457, doi. 10.5530/ijper.53.3.78

By:

Argade, Pallavi;
Patole, Vinita Chandrakant;
Pandit, Ashlesha Pravin

Publication type:

Article

Poly(lactic acid-co-glycolic acid) Nanospheres Improved the Oral Delivery of Candesartan Cilexetil.

Published in:

Indian Journal of Pharmaceutical Education & Research, 2018, v. 52, n. 3, p. 571, doi. 10.5530/ijper.51.4.86

By:

Nair, Anroop B.;
Al-Dhubiab, Bandar E.;
Shah, Jigar;
Attimarad, Mahesh;
Harsha, Sree

Publication type:

Article

Poly(lactic acid-co-glycolic acid) Nanospheres Improved the Oral Delivery of Candesartan Cilexetil.

Published in:

Indian Journal of Pharmaceutical Education & Research, 2017, v. 51, n. 4, p. 571, doi. 10.5530/ijper.51.4.86

By:

Nair, Anroop B.;
Al-Dhubiab, Bandar E.;
Shah, Jigar;
Attimarad, Mahesh;
Harsha, Sree

Publication type:

Article

Olmesartan enteropathy: an important cause of malabsorption and diarrhoea.

Published in:

2020

By:

Cook, Dane R.

Publication type:

Case Study

Investigation of the candesartan cilexetil antihypertensive drug microencapsulation by PLA‐PVP K30 biodegradable polymers: Experimental optimization and release kinetics modelling.

Published in:

Canadian Journal of Chemical Engineering, 2023, v. 101, n. 8, p. 4446, doi. 10.1002/cjce.24811

By:

Chabane, Ahmed;
Bouchal, Fatiha;
Hentabli, Mohamed;
Ayachi, Nabila;
Slama, Houssam Eddine;
Rezgui, Farouk;
Hammoumraoui, Lydia

Publication type:

Article

Candesartan Mediated Amelioration of Cisplatin-Induced Testicular Damage Is Associated with Alterations in Expression Patterns of Nephrin and Podocin.

Published in:

BioMed Research International, 2015, v. 2015, p. 1, doi. 10.1155/2015/273784

By:

Enatsu, Noritoshi;
Miyake, Hideaki;
Chiba, Koji;
Fujisawa, Masato

Publication type:

Article

Safety of Candesartan, Amlodipine, and Atorvastatin in Combination: Interaction Study in Healthy Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 2, p. 190, doi. 10.1002/cpdd.787

By:

Gundlach, Kristina;
Wolf, Katharina;
Salem, Isam;
Randerath, Olaf;
Seiler, Dan

Publication type:

Article

Pharmacokinetic and Bioequivalence Studies of a Newly Developed Branded Generic of Candesartan Cilexetil Tablets in Healthy Volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2017, v. 6, n. 5, p. 492, doi. 10.1002/cpdd.321

By:

Patel, Rajesh;
Palmer, Jonathan L.;
Joshi, Shashidhar;
Di Ció Gimena, Alejandro;
Esquivel, Florencia

Publication type:

Article